Literature DB >> 11865136

Smoking and Parkinson's disease in twins.

C M Tanner1, S M Goldman, D A Aston, R Ottman, J Ellenberg, R Mayeux, J W Langston.   

Abstract

OBJECTIVE: To test the hypothesis that cigarette smoking protects against the development of PD.
BACKGROUND: Smoking has been inversely associated with PD in many studies, but whether this reflects a biologic effect on the underlying disease process or merely confounding or selection bias remains uncertain.
METHODS: The authors compared smoking histories in male twin pairs identified from the National Academy of Sciences--National Research Council World War II Veteran Twins Cohort. The amount of cigarettes smoked (in pack-years) was collected until the time of PD onset in the affected twin or until the time of death for the unaffected twin, whichever came first. Differences in pack-years smoked until PD onset and until 10 and 20 years before onset were compared using paired t-tests. Comparisons were made overall and stratified by zygosity and concordance for PD. To assess the role of shared environment, correlation for smoking behaviors was compared between pairs concordant and discordant for PD.
RESULTS: Detailed smoking histories were available for 113 twin pairs in which at least one twin had PD (discordant pairs: 43 monozygotic [MZ], 50 dizygotic [DZ]; concordant pairs: 10 MZ, 10 DZ). Within-pair correlation for ever smoking was high in MZ pairs (phi = 0.47, p = 0.001) but not in DZ pairs (phi = 0.007, p = 0.96). In 33 discordant MZ pairs and 39 discordant DZ pairs in which at least one twin had smoked, the twins without PD smoked more than their brothers smoked (32.5 vs. 22.7 pack-years, p = 0.026). This was more marked in the MZ pairs (37.1 vs. 25.3 pack-years, p = 0.077) than in the DZ pairs (28.6 vs. 20.5 pack-years, p = 0.17). A similar relationship was seen when smoking dose was calculated only until 10 years before PD onset, suggesting that the lower dose of smoking in the twin with PD was not the result of early, undiagnosed disease.
CONCLUSION: Within twin pairs, risk of PD is inversely correlated with the dose (in pack-years) of cigarette smoking. This effect is most pronounced in MZ twins, despite the high correlation for smoking. Because MZ twins are genetically identical and are similar behaviorally, this difference is unlikely to result from either genetic factors or environmental confounders. These results are compatible with a true biologic protective effect of cigarette smoking.

Entities:  

Mesh:

Year:  2002        PMID: 11865136     DOI: 10.1212/wnl.58.4.581

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  44 in total

1.  Solvent exposures and Parkinson disease risk in twins.

Authors:  Samuel M Goldman; Patricia J Quinlan; G Webster Ross; Connie Marras; Cheryl Meng; Grace S Bhudhikanok; Kathleen Comyns; Monica Korell; Anabel R Chade; Meike Kasten; Benjamin Priestley; Kelvin L Chou; Hubert H Fernandez; Franca Cambi; J William Langston; Caroline M Tanner
Journal:  Ann Neurol       Date:  2011-11-14       Impact factor: 10.422

2.  Premotor Parkinson's disease: concepts and definitions.

Authors:  Andrew Siderowf; Anthony E Lang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

3.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

Review 4.  Inside-out neuropharmacology of nicotinic drugs.

Authors:  Brandon J Henderson; Henry A Lester
Journal:  Neuropharmacology       Date:  2015-02-04       Impact factor: 5.250

5.  Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.

Authors:  Masahiro Fujita; Masanori Ichise; Sami S Zoghbi; Jeih-San Liow; Subroto Ghose; Douglass C Vines; Janet Sangare; Jian-Qiang Lu; Vanessa L Cropley; Hidehiro Iida; Kyeong Min Kim; Robert M Cohen; William Bara-Jimenez; Bernard Ravina; Robert B Innis
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

6.  Physiology versus pathology in Parkinson's disease.

Authors:  Ken Nakamura; Robert H Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-10       Impact factor: 11.205

Review 7.  Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes.

Authors:  Hong Yuan; Jing-Chen Zheng; Ping Liu; Shao-Feng Zhang; Jian-Yang Xu; Li-Min Bai
Journal:  Neurosci Bull       Date:  2007-03       Impact factor: 5.203

8.  Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein.

Authors:  Sudhakar R Subramaniam; Iddo Magen; Nicholas Bove; Chunni Zhu; Vincent Lemesre; Garima Dutta; Chris Jean Elias; Henry A Lester; Marie-Francoise Chesselet
Journal:  Neurobiol Dis       Date:  2018-06-01       Impact factor: 5.996

Review 9.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

10.  Smoking and risk of skin cancer: a prospective analysis and a meta-analysis.

Authors:  Fengju Song; Abrar A Qureshi; Xiang Gao; Tricia Li; Jiali Han
Journal:  Int J Epidemiol       Date:  2012-10-11       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.